Does REVUMENIB Cause Electrocardiogram qt prolonged? 14 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 14 reports of Electrocardiogram qt prolonged have been filed in association with REVUMENIB (Revuforj). This represents 3.8% of all adverse event reports for REVUMENIB.
14
Reports of Electrocardiogram qt prolonged with REVUMENIB
3.8%
of all REVUMENIB reports
1
Deaths
6
Hospitalizations
How Dangerous Is Electrocardiogram qt prolonged From REVUMENIB?
Of the 14 reports, 1 (7.1%) resulted in death, 6 (42.9%) required hospitalization.
Is Electrocardiogram qt prolonged Listed in the Official Label?
Yes, Electrocardiogram qt prolonged is listed as a known adverse reaction in the official FDA drug label for REVUMENIB.
What Other Side Effects Does REVUMENIB Cause?
Off label use (57)
Platelet count decreased (50)
Nausea (49)
Product dose omission issue (40)
Death (38)
Vomiting (26)
Fatigue (24)
Pyrexia (22)
Differentiation syndrome (16)
Haemoglobin decreased (16)
What Other Drugs Cause Electrocardiogram qt prolonged?
QUETIAPINE (1,869)
OLANZAPINE (1,325)
RIBOCICLIB (1,020)
AMIODARONE (1,000)
HYDROXYCHLOROQUINE (992)
CLOZAPINE (958)
CITALOPRAM HYDROBROMIDE (917)
ESCITALOPRAM OXALATE (899)
ONDANSETRON (881)
BUPROPION (853)
Which REVUMENIB Alternatives Have Lower Electrocardiogram qt prolonged Risk?
REVUMENIB vs REYATAZ
REVUMENIB vs REZAFUNGIN
REVUMENIB vs RIBASPHERE
REVUMENIB vs RIBAVIRIN
REVUMENIB vs RIBOCICLIB